Subramanian Loganathan, Jelle Klein, Amina Z Haggag, Andrew A Shaw, Tracey E. Lawrence, Mark S. Liu, Madhava Rao Betha. "A randomized, double-blind, three-arm, parallel group, phase 1 study to assess the pharmacokinetics, safety, and tolerability of PERT-IJS following a single dose of 420 mg intravenous infusion compared to the EU- and US-marketed drug product (pertuzumab; PERT) in healthy male volunteers.." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.16_suppl.e13009